Insuring your health: Health law requires continued coverage for patients in clinical trials

Download PDF Copy

Aug 25 2010

In her latest Kaiser Health News consumer column, Michelle Andrews writes: "When Richard Crusoe was diagnosed with a rare form of soft tissue cancer called liposarcoma, the retired firefighter and his family pinned their hopes of slowing the cancer's advance on a drug that was being tested in a clinical trial" (Andrews, 8/24). Read entire column.

This article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Medical Research News | Medical Condition News | Healthcare News

Tags: Cancer, Clinical Trial, Liposarcoma

Comments (0)

Download PDF Copy

Suggested Reading

Discovery of nuclear speckles may improve cancer treatment decisions

Discovery of nuclear speckles may improve cancer treatment decisions

Researchers grow tumor organoids from blood to tackle breast cancer metastasis

Researchers grow tumor organoids from blood to tackle breast cancer metastasis

New immunotherapy shows long-term benefits in preventing squamous cell carcinoma

New immunotherapy shows long-term benefits in preventing squamous cell carcinoma

Study reveals major differences between human and mouse PD-1 in cancer research

Study reveals major differences between human and mouse PD-1 in cancer research

Scientists launch public resource to classify cancer subtypes for better diagnosis

Scientists launch public resource to classify cancer subtypes for better diagnosis

Genetic mutation in esophageal cancer found to have dual effects

Genetic mutation in esophageal cancer found to have dual effects

Topical immunotherapy clears precancerous skin lesions and reduces cancer risk

Topical immunotherapy clears precancerous skin lesions and reduces cancer risk

Study identifies best imaging methods for evaluating brain tumor response in melanoma patients

Study identifies best imaging methods for evaluating brain tumor response in melanoma patients

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Advanced imaging technology detects undiagnosed metastases in high-risk prostate cancer